ReP USP - Resultado da busca

Artigo de periodico
Drug repurposing in chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi In vitro and in vivo (2022)
Pandey, Ramendra Pati; Nascimento, Marilda Savoia ; Franco, Caio Haddad ; Bortoluci, Karina ; Silva, Marcelo Nunes da ; Zingales, Bianca ; Gibald, Daniel; Barrios, Leda Castaño; Vieira, Joseli Lannes ; Cariste, Leonardo Moro; Vasconcelos, Jose Ronnie ; Moraes, Carolina Borsoi ; Freitas Junior, Lucio H; Kalil Filho, Jorge Elias ; Alcântara, Laura; Cunha Neto, Edecio
Source: Antimicrobial Agents and Chemotherapy. Unidades: FM, IQ
Subjects: DOENÇA DE CHAGAS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PANDEY, Ramendra Pati et al. Drug repurposing in chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi In vitro and in vivo. Antimicrobial Agents and Chemotherapy, v. 66, n. 11, p. 1-17, 2022Tradução . . Disponível em: https://doi.org/10.1128/aac.00284-22. Acesso em: 14 nov. 2024.
APA
Pandey, R. P., Nascimento, M. S., Franco, C. H., Bortoluci, K., Silva, M. N. da, Zingales, B., et al. (2022). Drug repurposing in chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi In vitro and in vivo. Antimicrobial Agents and Chemotherapy, 66( 11), 1-17. doi:10.1128/aac.00284-22
NLM
Pandey RP, Nascimento MS, Franco CH, Bortoluci K, Silva MN da, Zingales B, Gibald D, Barrios LC, Vieira JL, Cariste LM, Vasconcelos JR, Moraes CB, Freitas Junior LH, Kalil Filho JE, Alcântara L, Cunha Neto E. Drug repurposing in chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi In vitro and in vivo [Internet]. Antimicrobial Agents and Chemotherapy. 2022 ; 66( 11): 1-17.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1128/aac.00284-22
Vancouver
Pandey RP, Nascimento MS, Franco CH, Bortoluci K, Silva MN da, Zingales B, Gibald D, Barrios LC, Vieira JL, Cariste LM, Vasconcelos JR, Moraes CB, Freitas Junior LH, Kalil Filho JE, Alcântara L, Cunha Neto E. Drug repurposing in chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi In vitro and in vivo [Internet]. Antimicrobial Agents and Chemotherapy. 2022 ; 66( 11): 1-17.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1128/aac.00284-22
Artigo de periodico
Investigating the structure-activity relationships of N’-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds (2018)
Palace-Berl, Fanny; Pasqualoto, Kerly Fernanda Mesquita; Zingales, Bianca ; Moraes, Carolina Borsoi; Bury, Mariana; Franco, Caio Haddad; Silva Neto, Adelson Lopes da; Murayama, João Sussumu; Nunes, Solange Lessa; Silva, Marcelo Nunes da; Tavares, Leoberto Costa
Source: European Journal of Medicinal Chemistry. Unidades: IQ, FCF
Subjects: TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PALACE-BERL, Fanny et al. Investigating the structure-activity relationships of N’-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds. European Journal of Medicinal Chemistry, v. 144, p. 29-40, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2017.12.011. Acesso em: 14 nov. 2024.
APA
Palace-Berl, F., Pasqualoto, K. F. M., Zingales, B., Moraes, C. B., Bury, M., Franco, C. H., et al. (2018). Investigating the structure-activity relationships of N’-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds. European Journal of Medicinal Chemistry, 144, 29-40. doi:10.1016/j.ejmech.2017.12.011
NLM
Palace-Berl F, Pasqualoto KFM, Zingales B, Moraes CB, Bury M, Franco CH, Silva Neto AL da, Murayama JS, Nunes SL, Silva MN da, Tavares LC. Investigating the structure-activity relationships of N’-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds [Internet]. European Journal of Medicinal Chemistry. 2018 ; 144 29-40.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ejmech.2017.12.011
Vancouver
Palace-Berl F, Pasqualoto KFM, Zingales B, Moraes CB, Bury M, Franco CH, Silva Neto AL da, Murayama JS, Nunes SL, Silva MN da, Tavares LC. Investigating the structure-activity relationships of N’-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds [Internet]. European Journal of Medicinal Chemistry. 2018 ; 144 29-40.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ejmech.2017.12.011
Artigo de periodico
Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease (2010)
Moreno, Margoth Mitchela Vigo; D'Ávila, Daniella A; Silva, Marcelo Nunes da; Galvão, Lúcia Maria da Cunha; Macedo, Andrea M; Chiari, Egler; Gontijo, Eliane Dias; Zingales, Bianca
Source: Memórias do Instituto Oswaldo Cruz. Unidade: IQ
Subjects: TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENO, Margoth Mitchela Vigo et al. Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease. Memórias do Instituto Oswaldo Cruz, v. 105, n. 7, 2010Tradução . . Disponível em: https://doi.org/10.1590/s0074-02762010000700014. Acesso em: 14 nov. 2024.
APA
Moreno, M. M. V., D'Ávila, D. A., Silva, M. N. da, Galvão, L. M. da C., Macedo, A. M., Chiari, E., et al. (2010). Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease. Memórias do Instituto Oswaldo Cruz, 105( 7). doi:10.1590/s0074-02762010000700014
NLM
Moreno MMV, D'Ávila DA, Silva MN da, Galvão LM da C, Macedo AM, Chiari E, Gontijo ED, Zingales B. Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease [Internet]. Memórias do Instituto Oswaldo Cruz. 2010 ; 105( 7):[citado 2024 nov. 14 ] Available from: https://doi.org/10.1590/s0074-02762010000700014
Vancouver
Moreno MMV, D'Ávila DA, Silva MN da, Galvão LM da C, Macedo AM, Chiari E, Gontijo ED, Zingales B. Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease [Internet]. Memórias do Instituto Oswaldo Cruz. 2010 ; 105( 7):[citado 2024 nov. 14 ] Available from: https://doi.org/10.1590/s0074-02762010000700014

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Non normalized affiliation